Publications by authors named "Zhantao Lin"

Claim this Profile
M
Mirikizumab Pharmacokinetics and Exposure-Response in Patients With Moderately-To-Severely Active Crohn's Disease: Results From Two Randomized Studies.
Laiyi Chua, Yuki Otani, Zhantao Lin, Stuart Friedrich, Frederick Durand

Clin Transl Sci· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bowel Urgency in Crohn's Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study.
Vipul Jairath, Geert D'Haens, Bruce E Sands, Simon Travis, María Chaparro, Zhantao Lin

Clin Gastroenterol Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of mirikizumab in patients with moderately-to-severely active Crohn's disease: a phase 3, multicentre, randomised, double-blind, placebo-controlled and active-controlled, treat-through study.
Marc Ferrante, Geert D'Haens, Vipul Jairath, Silvio Danese, Minhu Chen, Zhantao Lin, Michelle Ugolini Lopes

Lancet· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design considerations for two-stage enrichment clinical trials.
Rosamarie Frieri, William Fisher Rosenberger, Nancy Flournoy, Zhantao Lin

Biometrics· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Semiparametric analysis of zero-inflated recurrent events with a terminal event.
Chenchen Ma, Tao Hu, Zhantao Lin

Stat Med· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis